Results 61 to 70 of about 2,522 (173)
Polymeric Nanoparticles for the Diagnosis and Treatment of Snakebite
Snakebite envenomation affects between 1.8 and 5.5 million people annually, many of whom suffer disabilities or even death. Current antivenoms are composed of plasma‐derived antibodies. However, there remains an underexplored opportunity to utilise polymer‐based nanoparticles.
Neil Prabhakar +2 more
wiley +1 more source
ABSTRACT Poisoning among older adults poses unique challenges due to age‐related physiological changes, polypharmacy, and comorbidities. As Thailand transitions to a super‐aged society, this study characterizes poisoning patterns in Thai older adults to inform prevention strategies.
Pornchanok Monkaew +3 more
wiley +1 more source
Introduction: Neurotoxic envenomation often presents with non-specific neurological symptoms and minimal local signs, which can delay appropriate diagnosis and treatment.
T. Neithiya +2 more
doaj +1 more source
Background Snakebite envenomation (SBE) is a tropical disease with significant global morbidity and mortality, particularly affecting low‐resource settings. During pregnancy, SBE poses unique challenges, increasing both maternal and fetal mortality. Limited access to antivenom and delayed treatment further worsen outcomes.
Felipe Loza-Hernandez +4 more
wiley +1 more source
Clinical Characteristics of Snakebite Envenomings in Taiwan
Snakebite envenomings continue to represent a major public health concern in Taiwan because of the presence of various venomous snakes whose habitats intersect with human activities. This review provides a comprehensive analysis of the clinical characteristics, complications, and management strategies associated with snakebite envenomings in Taiwan ...
Yan-Chiao Mao +5 more
openaire +3 more sources
Exploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation [PDF]
Phospholipase A2s (PLA2) is a major component of snake venom with diverse pathologic toxicities and, therefore, a potential target for antivenom therapy. Varespladib was initially designed as an inhibitor of mammal PLA2s, and was recently repurposed to a broad-spectrum inhibitor of PLA2 in snake venom.
Yiding Wang +5 more
openaire +3 more sources
Background Snake and scorpion bites pose a significant public health burden, with an estimated global annual morbidity rate of 5.4 million and 1.2 million, respectively. Various first‐aid methods are commonly practiced in communities, aiming to improve the chances of survival after bites.
Petrus Uushona +2 more
wiley +1 more source
Background Neglected tropical diseases (NTDs) disproportionately affect impoverished populations in tropical regions. Despite their significant health burden, data on NTD prevalence and distribution are limited in many areas, including Khartoum State, Sudan.
Babiker Mohamed Rahamtalla +1 more
wiley +1 more source
Japanese Traditional Medicine for the Treatment of Swelling Caused by Gloydius blomhoffii Snakebites
Traditional &Kampo Medicine, Volume 13, Issue 1, April 2026.
Yuki Nakano +4 more
wiley +1 more source
Snakebite envenomation requires rapid venom identification for effective treatment, a need unmet by current diagnostics in China. This study aimed to develop a rapid, multiplex immunofluorescence lateral flow assay for the simultaneous detection of four major venomous snakes: Deinagkistrodon acutus, Bungarus multicinctus, Naja atra, and Agkistrodon ...
Linsheng Zeng +13 more
wiley +1 more source

